Drug
Livmoniplimab
Livmoniplimab: highest development phase Phase 2, developed by AbbVie. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- AbbVie
Trials
| Drug | Phase | Indication |
|---|---|---|
| Livmoniplimab NCT06632951 | Phase 2 | Urothelial Carcinoma |
Latest
No recent events.
Follow Livmoniplimab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.